69 studies found for:    "Primary progressive aphasia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Language in Primary Progressive Aphasia
Condition: Primary Progressive Aphasia
Intervention:
2 Completed
Has Results
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Conditions: Frontal Lobe Dementia;   Frontotemporal Lobe Dementia;   Semantic Dementia
Interventions: Drug: memantine;   Drug: Placebo pill
3 Completed Oxytocin and Social Cognition in Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick's Disease
Intervention: Drug: intranasal oxytocin
4 Completed Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Vascular Dementia;   Fronto-temporal Dementia;   Primary Progressive Aphasia;   Parkinson' Disease Dementia;   Mixed Dementia
Intervention:
5 Unknown  Language Treatment for Progressive Aphasia
Conditions: Primary Progressive Aphasia;   Nonfluent Progressive Aphasia;   Semantic Dementia
Intervention: Behavioral: Errorless learning
6 Recruiting Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Conditions: Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia;   Paget Disease of Bone;   Frontotemporal Dementia;   Myopathy
Intervention:
7 Unknown  Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
8 Completed A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Pick Complex
Intervention: Drug: galantamine hydrobromide
9 Recruiting PiB PET Scanning in Speech and Language Based Dementias
Conditions: PPA;   Primary Progressive Aphasia;   Aphasia;   Non-fluent Aphasia;   Semantic Dementia;   Apraxia of Speech;   Primary Progressive Nonfluent Aphasia;   Progressive Aphasia
Interventions: Drug: C-11 PiB;   Drug: F-18 FDG
10 Completed Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: memantine hydrochloride
11 Completed Safety Study of Intranasal Oxytocin in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin;   Drug: Saline Nasal Mist
12 Completed Direct Current Brain Polarization in Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Procedure: Direct Current Polarization
13 Terminated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Amyotrophic Lateral Sclerosis
Intervention:
14 Recruiting Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
Condition: Frontotemporal Dementia
Interventions: Drug: Intranasal oxytocin;   Drug: Saline Nasal Mist
15 Completed Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: Citalopram
16 Recruiting Longitudinal Study of Cognition With Niemann-Pick Disease, Type C
Condition: Niemann-Pick Disease, Type C
Intervention:
17 Completed
Has Results
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Condition: Niemann-Pick Disease, Type C
Intervention: Drug: N-Acetyl Cysteine
18 Recruiting Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Conditions: Frontotemporal Dementia;   Frontotemporal Degeneration;   Alzheimer's Disease;   Social Behavior
Intervention:
19 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
20 Recruiting Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Condition: Neimann-Pick Disease
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years